Mallinckrodt q2 loss per share $11.04

Reports earnings for the second quarter 2020 and highlights pipeline advancements.q2 loss per share $11.04.q2 adjusted earnings per share $1.89.q2 revenue $166.5 million.continues to work to resolve outstanding issues related to opioids, acthar gel, and other risks.qtrly reported gaap net sales were impacted by retrospective one-time acthar gel medicaid liability.normalized operating results also displayed a contraction this quarter due to covid-19 health crisis.possible that mallinckrodt plc and most of its subsidiaries could file for chapter 11 reorganization in the near term.no final determination has been made with respect to chatper 11 reorganization.expect current challenges to continue in the back half of the year.working with external advisors to explore a range of options.engaging in dialogue with financial creditors and litigation claimants and their advisors.q2 earnings per share view $1.34 -- refinitiv ibes data.
MNK Ratings Summary
MNK Quant Ranking